Tweets: SNY (Sanofi-aventis Sa)

MolekuleBio via Twitter 07:06 AM  05/23/13 reply  |  re-tweet

$JNJ (Msgs, Twts) StaphVax candidate looking promising, but is in highly competitive landscape with others from $PFE (Msgs, Twts), $GSK (Msgs, Twts), $NVS (Msgs, Twts) & $SNY (Msgs, Twts) #MolekuleInsight

SanofiUS via Twitter 03:36 PM  05/22/13 reply  |  re-tweet

ICYMI: $SNY (Msgs, Twts) Pres of NA #Pharma discusses #Alzheimer’s research & strategy on #SpeakingofSanofi: http://t.co/TBKxGOHEip

chasingthealpha via Twitter 03:28 PM  05/22/13 reply  |  re-tweet

RT @gansubpodar: @Magicsia @dsobek @chasingthealpha Only company to have made $ on inhaled insulin is $SNY (Msgs, Twts) when they sold Exubera rights to $PFE (Msgs, Twts) for $2B

gansubpodar via Twitter 03:28 PM  05/22/13 reply  |  re-tweet

@Magicsia @dsobek @chasingthealpha Only company to have made $ on inhaled insulin is $SNY (Msgs, Twts) when they sold Exubera rights to $PFE (Msgs, Twts) for $2B

SanofiUS via Twitter 12:45 PM  05/22/13 reply  |  re-tweet

Patrick Barry, $SNY (Msgs, Twts) VP, CV & Specialty Care, shares thoughts on #Asthma & #Allergy Awareness Month: http://t.co/R4nWeD3Udf [VIDEO] #yam

chasingthealpha via Twitter 11:54 AM  05/22/13 reply  |  re-tweet

@dsobek @StuckInStock data looks good for niche market. Unsure of $SNY (Msgs, Twts) economics on it.

Quantumandlotus via Twitter 10:32 AM  05/22/13 reply  |  re-tweet

What an wonderful day to be a biotech trader ! $BMY (Msgs, Twts), $GILD (Msgs, Twts), $GSK (Msgs, Twts), $SNY (Msgs, Twts), $SGEN (Msgs, Twts), $SUPN (Msgs, Twts)

pharmalot via Twitter 08:00 AM  05/22/13 reply  |  re-tweet

Pharmalot.. Pharmalittle.. Good Morning.. coffee, headlines & sunny spirits http://t.co/h4XdSyTpSz #pharma $REGN (Msgs, Twts) $IPXL (Msgs, Twts) $GSK (Msgs, Twts) $SNY (Msgs, Twts) $JNJ (Msgs, Twts) $NVS (Msgs, Twts)

daily_finance via Twitter 06:48 AM  05/22/13 reply  |  re-tweet

#Sony mulls activist investor's idea to spin-off part of its entertainment unit http://t.co/FP1ksVUOyI $SNY (Msgs, Twts)

Ro_Patel via Twitter 01:49 AM  05/22/13 reply  |  re-tweet

12-wk study, number of asthma attacks or other outbreaks of symptoms decreased by 87% in those getting dupilumab - $SNY (Msgs, Twts) $REGN (Msgs, Twts)

Ro_Patel via Twitter 01:48 AM  05/22/13 reply  |  re-tweet

12-wk study, number of asthma attacks or other outbreaks of symptoms decreased by 87% in those getting dupilumab - $SNY (Msgs, Twts)

LifeSciAdvisors via Twitter 03:06 PM  05/21/13 reply  |  re-tweet

Elan Continues to Make Baffling Strategic Decisions ($ELN (Msgs, Twts), $THRX (Msgs, Twts), $GSK (Msgs, Twts), $PRTA (Msgs, Twts), $SNY (Msgs, Twts)). http://t.co/rky7ODeZcJ

LifeSciAdvisors via Twitter 03:03 PM  05/21/13 reply  |  re-tweet

Elan Continues to Make Baffling Strategic Decisions ($ELN (Msgs, Twts), $THRX (Msgs, Twts), $GSK (Msgs, Twts), $PRTA (Msgs, Twts), $SNY (Msgs, Twts)). http://t.co/6cO6E6DMak

Quantumandlotus via Twitter 11:45 AM  05/21/13 reply  |  re-tweet

@Quantumandlotus $SNY (Msgs, Twts) removed from my sell list today :)

groman100 via Twitter 11:39 AM  05/21/13 reply  |  re-tweet

Ampio Pharma Initiates Phase III, Investors Extend Momentum http://t.co/1yC7KFHnsD $SNY (Msgs, Twts) $AMPE (Msgs, Twts)

SeekingAlpha via Twitter 09:10 AM  05/21/13 reply  |  re-tweet

Will Influenza A H7N9 Generate Opportunities For Pharma? http://t.co/w9z41i188M $GILD (Msgs, Twts) $NVAX (Msgs, Twts) $NVS (Msgs, Twts) $RHHBY (Msgs, Twts).OB $SNY (Msgs, Twts) $GSK (Msgs, Twts)

brettchase via Twitter 09:08 AM  05/21/13 reply  |  re-tweet

Sanofi, Regeneron asthma drug seen as breakthrough $REGN (Msgs, Twts) $SNY (Msgs, Twts) http://t.co/MSha6pqTMm

MolekuleBio via Twitter 09:06 AM  05/21/13 reply  |  re-tweet

Novel $REGN (Msgs, Twts) & $SNY (Msgs, Twts) #asthma agent treats underlying elusive targets of disease - reduces 87% of asthmatic episodes #ATS2013 #MolekuleInsight

micenter via Twitter 08:52 AM  05/21/13 reply  |  re-tweet

Sanofi $SNY (Msgs, Twts) Could Break Through $54.59 Resistance Level ( http://t.co/8dEFQJgDDR )

AndyBiotech via Twitter 08:29 AM  05/21/13 reply  |  re-tweet

@Reuters story on Dupilumab: Regeneron, Sanofi asthma drug seen as potential game changer -> http://t.co/QEXJRcqyIm $SNY (Msgs, Twts) $REGN (Msgs, Twts)

atorsoli via Twitter 07:07 AM  05/21/13 reply  |  re-tweet

Interesting move to #BioMerieux for #Cartier, who spent most of his professional carreer at #Sanofi $SNY (Msgs, Twts) $BIM (Msgs, Twts)

atorsoli via Twitter 07:04 AM  05/21/13 reply  |  re-tweet

#Sanofi's Nicolas #Cartier appointed corporate VP, industrial microbiology unit of #BioMerieux, effective starting today! $SNY (Msgs, Twts) $BIM (Msgs, Twts)

Quantumandlotus via Twitter 01:36 AM  05/21/13 reply  |  re-tweet

$SNY (Msgs, Twts) did not do well that, think I'm going to sell

Ethane28 via Twitter 05:59 PM  05/20/13 reply  |  re-tweet

RT @svedding: Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill http://t.co/PePKXSpKfo $BMRN (Msgs, Twts) $PFE (Msgs, Twts) $SNY (Msgs, Twts) $TEVA (Msgs, Twts) $CPRX (Msgs, Twts)

FiercePharma via Twitter 12:20 PM  05/20/13 reply  |  re-tweet

RT @EricPFierce: Sanofi's Christopher Viehbacher was at the bottom of the list of top paid pharma CEOs. http://t.co/Z1lkO9rZaA #pharma $SNY (Msgs, Twts)